SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------------
Form 8-K
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): February 19, 2004
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
Florida 2-70197 59-1564329
(State or other (Commission File Number) (IRS Employer
jurisdiction Identification No.)
of Incorporation)
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: 954/587-6280
Item 2. Acquisition or Disposition of Assets
On December 29, 2003, the Registrant executed a Letter of Intent to acquire
the operating assets of Clear Cote Corporation of St. Petersburg, Florida. As of
this date the respective parties have reached an impasse and, accordingly the
Letter of Intent and the contemplated transaction have been terminated without a
successful conclusion.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
OCEAN BIO-CHEM, INC.
Date: February 20, 2004 By: /s/ Peter G. Dornau
--------------------
Name: Peter G. Dornau
Title: Chairman of the Board of
Directors and Chief
Executive Officer
Date: February 20, 2004 By: /s/ Edward Anchel
-------------------
Name: Edward Anchel
Title: Chief Financial Officer